Funding Rounds
Achilles Therapeutics Series B (2019, $116M)
Achilles TherapeuticsImmunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.
Summary
Stage: Series B
Raised Amount: $116.00M
Raised Date: 2019-03-01
Stage: Series B
Raised Amount: $116.00M
Raised Date: 2019-03-01
